ZA978015B - Tetrahydronaphthalene derivatives and their therapeutic use - Google Patents

Tetrahydronaphthalene derivatives and their therapeutic use

Info

Publication number: ZA978015B
Authority: ZA; South Africa
Prior art keywords: therapeutic use; tetrahydronaphthalene derivatives; tetrahydronaphthalene; derivatives; selectins
Prior art date: 1996-09-05

Application number

ZA978015A

Other languages

English (en)

Inventor

Richard John Kenneth Taylor

Paul Vincent Murphy

John Gary Montana

David Thomas Manallack

Original Assignee

Chiroscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-05

Filing date

1997-09-05

Publication date

1998-09-07

1997-09-05 Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd

1998-09-07 Publication of ZA978015B publication Critical patent/ZA978015B/xx

Links

230000001225 therapeutic effect Effects 0.000 title abstract 2
CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 title 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 abstract 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 abstract 1
102000003800 Selectins Human genes 0.000 abstract 1
108090000184 Selectins Proteins 0.000 abstract 1
230000021164 cell adhesion Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Virology (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA978015A 1996-09-05 1997-09-05 Tetrahydronaphthalene derivatives and their therapeutic use ZA978015B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9618520.2A GB9618520D0 (en)	1996-09-05	1996-09-05	Compounds and their therapeutic use

Publications (1)

Publication Number	Publication Date
ZA978015B true ZA978015B (en)	1998-09-07

Family

ID=10799452

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA978015A ZA978015B (en)	1996-09-05	1997-09-05	Tetrahydronaphthalene derivatives and their therapeutic use

Country Status (11)

Country	Link
US (1)	US6133240A (es)
EP (1)	EP0931086B1 (es)
JP (1)	JP2001500490A (es)
AT (1)	ATE217006T1 (es)
AU (1)	AU707160B2 (es)
CA (1)	CA2264737A1 (es)
DE (1)	DE69712351T2 (es)
ES (1)	ES2173477T3 (es)
GB (1)	GB9618520D0 (es)
WO (1)	WO1998009977A1 (es)
ZA (1)	ZA978015B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003249641B2 (en)	2002-05-16	2009-08-20	Glycomimetics, Inc.	Compounds and methods for inhibiting selectin-mediated function
JP2006502986A (ja) *	2002-07-03	2006-01-26	グリコミメティクス，インコーポレイテッド	新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
US20040219158A1 (en) *	2003-05-02	2004-11-04	Glycomimetics, Inc.	Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
EP1685145A2 (en) *	2003-11-19	2006-08-02	GlycoMimetics, Inc.	Glycomimetic antagonists for both e- and p-selectins
US7361644B2 (en) *	2003-11-19	2008-04-22	Glycomimetics, Inc.	Specific antagonist for both E- and P-selectins
WO2006127906A1 (en) *	2005-05-25	2006-11-30	Glycomimetics, Inc.	Heterobifunctional compounds for selectin inhibition
JP5175190B2 (ja) *	2005-08-09	2013-04-03	グリコミメティクス，インコーポレイテッド	シュードモナス由来のｐａ−ｉｌレクチン、ｐａ−ｉｉｌレクチンまたは両方のレクチンのグリコミメティック阻害剤
US7728117B2 (en)	2005-09-02	2010-06-01	Glycomimetics, Inc.	Heterobifunctional pan-selectin inhibitors
US20090176717A1 (en) *	2006-06-01	2009-07-09	Glycomimetics, Inc.	Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
EP2074132B1 (en)	2006-10-12	2013-05-15	GlycoMimetics, Inc.	Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2457573A1 (en) *	2007-02-09	2012-05-30	GlycoMimetics, Inc.	Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
US8039442B2 (en) *	2007-07-18	2011-10-18	Glycomimetics, Inc.	Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en)	2008-04-08	2009-10-15	Glycomimetics, Inc.	Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2727788A1 (en)	2008-06-13	2009-12-17	Glycomimetics, Inc.	Treatment of cancers of the blood using selected glycomimetic compounds
US8410066B2 (en) *	2009-05-01	2013-04-02	Glycomimetics, Inc.	Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
US8921328B2 (en)	2010-09-14	2014-12-30	Glycomimetics, Inc.	E-selectin antagonists
SI2794626T1 (en)	2011-12-22	2018-02-28	Glycomimetics, Inc.	E-SELECTINE ANTAGONIST COMPOUNDS
LT2928476T (lt)	2012-12-07	2018-05-25	Glycomimetics, Inc.	Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
HUE045542T2 (hu)	2014-12-03	2019-12-30	Glycomimetics Inc	E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
WO2017127422A1 (en)	2016-01-22	2017-07-27	Glycomimetics, Inc.	Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en)	2016-03-02	2017-09-08	Glycomimetics, Inc.	Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en)	2016-08-08	2022-03-09	GlycoMimetics, Inc.	Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
CA3037850A1 (en)	2016-10-07	2018-04-12	Glycomimetics, Inc.	Highly potent multimeric e-selectin antagonists
CA3054605A1 (en)	2017-03-15	2018-09-20	Glycomimetics, Inc.	Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en)	2017-11-30	2020-10-07	GlycoMimetics, Inc.	Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
EP3732186A1 (en)	2017-12-29	2020-11-04	GlycoMimetics, Inc.	Heterobifunctional inhibitors of e-selectin and galectin-3
US11707474B2 (en)	2018-03-05	2023-07-25	Glycomimetics, Inc.	Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en)	2018-12-27	2023-12-19	Glycomimetics, Inc.	Heterobifunctional inhibitors of E-selectin and galectin-3
USD936390S1 (en) *	2021-04-23	2021-11-23	Qingdao Jinxiang Tongzhen Textile Co., Ltd.	Wedge pillow set
USD936391S1 (en) *	2021-04-26	2021-11-23	Qingdao Jinxiang Tongzhen Textile Co., Ltd.	Wedge pillow set

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639734A (en) *	1994-12-20	1997-06-17	Esko; Jeffrey D.	Disaccharide inflammation inhibitors and uses thereof

1996
- 1996-09-05 GB GBGB9618520.2A patent/GB9618520D0/en active Pending
1997
- 1997-09-05 DE DE69712351T patent/DE69712351T2/de not_active Expired - Fee Related
- 1997-09-05 JP JP10512372A patent/JP2001500490A/ja active Pending
- 1997-09-05 WO PCT/GB1997/002406 patent/WO1998009977A1/en not_active Ceased
- 1997-09-05 AT AT97939057T patent/ATE217006T1/de not_active IP Right Cessation
- 1997-09-05 ZA ZA978015A patent/ZA978015B/xx unknown
- 1997-09-05 AU AU41282/97A patent/AU707160B2/en not_active Ceased
- 1997-09-05 US US08/924,688 patent/US6133240A/en not_active Expired - Fee Related
- 1997-09-05 EP EP97939057A patent/EP0931086B1/en not_active Expired - Lifetime
- 1997-09-05 CA CA002264737A patent/CA2264737A1/en not_active Abandoned
- 1997-09-05 ES ES97939057T patent/ES2173477T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE217006T1 (de)	2002-05-15
ES2173477T3 (es)	2002-10-16
CA2264737A1 (en)	1998-03-12
WO1998009977A1 (en)	1998-03-12
JP2001500490A (ja)	2001-01-16
AU4128297A (en)	1998-03-26
US6133240A (en)	2000-10-17
AU707160B2 (en)	1999-07-01
DE69712351T2 (de)	2002-11-07
DE69712351D1 (de)	2002-06-06
GB9618520D0 (en)	1996-10-16
EP0931086A1 (en)	1999-07-28
EP0931086B1 (en)	2002-05-02

Publication	Publication Date	Title
GB9618520D0 (en)	1996-10-16	Compounds and their therapeutic use
GB9514473D0 (en)	1995-09-13	Chemical compounds
EP1193270A3 (en)	2002-04-17	Pyrrolobenzodiazepines
MY120235A (en)	2005-09-30	Aryloxyarylsulfonylamino hydroxamic acid derivatives
MD1616F2 (en)	2001-02-28	Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
AU5788396A (en)	1996-11-21	Methods of inhibition or killing of cancer cells
EP0494175A4 (en)	1993-05-05	Compositions for cell adhesion inhibition and methods of use
AU4960297A (en)	1998-06-10	Bicyclic aryl carboxamides and their therapeutic use
ZA974022B (en)	1997-12-09	Key intermediates in the manufacture of simvastatin.
AU3284395A (en)	1996-04-04	Synthesis of 1,1,1,3,3,-pentafluoropropane
ZA861708B (en)	1986-11-26	Cyclopenta(d)pyrimidine derivatives,their preparation and use
AU6889398A (en)	1998-11-13	In-situ generation of zinc pyrithione
BG103369A (en)	2000-05-31	Method for the prevention of the cancer of the breast
CA2269217A1 (en)	1998-04-30	New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives
AU6381996A (en)	1996-12-30	Inhibition of cancer cell growth, proliferation and metastas is using n,n'-dibenzyl-alpha,omega-diaminoalkanes
EP1051173A4 (en)	2002-07-31	1,3,4-OXADIAZOLONVERBINDUNGEN
IL133597A0 (en)	2001-04-30	New combination of antiasthma medicaments
AU4498799A (en)	2000-01-10	Method of preparing 5- or 8-bromoisoquinoline derivatives
MX9603087A (es)	1997-01-31	Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
HUT76060A (en)	1997-06-30	A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
AUPM493194A0 (en)	1994-05-05	Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
BG101309A (en)	1997-10-31	New method for the preparation of 3,4-dihydroxy-5-nitrobenzaldenyde
HUT77177A (hu)	1998-03-02	Gyomirtó hatású (5-hidroxi-pirazol-4-il)-karbonil-szubsztituált szacharinszármazékok, eljárás előállításukra, a vegyületeket tartalmazó gyomirtó készítmények és alkalmazásuk
AUPM463794A0 (en)	1994-04-14	Inhibition of growth of cancer cells by carnosine
SG81238A1 (en)	2001-06-19	Use of triphenylmethyl-1,2,3-triazoles